Complexa
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2425 Sidney St, Pittsburgh, Pennsylvania...Phone Number
(484) 329-8436Website
www.complexarx.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Complexa
Complexa Inc. is a clinical stage biopharmaceutical company focused on transforming the lives of patients burdened with severe and life-threatening fibrosis and inflammatory diseases.Explore more
Complexa Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Complexa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Complexa is spiking on competitors!
Click to see if Complexa had a recent Job posting/layoffs
Check if Complexa has recently received funding, and reach out quickly before it becomes old news!
Complexa, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Complexa
Funding: Get notified immidiatlly once Complexa has new funding data
Earning: See what the market has to say on Complexa recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Complexa launches new products
Recommended Actions
Reach out to Masked Content who joined Complexa as Masked Content
Find 2 more new buyers
Compare Similar Companies to Complexa
Compare insights from companies similar to Complexa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Complexa is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Complexa is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Complexa.
Complexa financials insights
Gather financial insights about Complexa, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$2M
Series A
$3.6M
2013
Debt
$1.4M
Private Equity
$200K
2014
Series B
$14.8M
2015
Debt
$4M
2016
Debt
$950K
Debt
$1M
2017
Series C
$62M
2020
Debt
$150K
Complexa Tech Stack
A closer look at the technologies used by Complexa
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Funding
Complexa has received an SBA PPP loan for $150,000-350,000 from Wells Fargo Bank.
Funding
Complexa , Inc. has received an SBA PPP loan for $150,000-350,000 from Wells Fargo Bank, National Association.
New Hire
Executive Move
Executive Moves, New Hire
Complexa News & Media
Complexa Names Elisabeth Leiderman, MD, MBA, Chief Business Officer
BERWYN, Pa.--(BUSINESS WIRE)--Complexa Inc. today announced the appointment of Elisabeth Leiderman, MD, MBA, as Chief Business Officer. Dr. Leiderman formerly served as Senior Vice President, Head of Corporate Development for Fortress Biotech where she led strategy and oversight for all aspects of corporate development for the company’s 10 subsidiaries. “Elisabeth is a proven leader with more than 15 years of experience in the biotech, pharmaceutical and healthcare investment banking industriesComplexa Names Theodore Danoff, MD, PhD, Chief Medical Officer
BERWYN, Pa.--(BUSINESS WIRE)--Complexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. Dr. Danoff formerly served as Chief Medical Officer and Senior Vice President, Clinical and Medical Affairs for Clarus Therapeutics where he led strategy and oversight for all aspects of clinical development and medical affairs as well as regulatory affairs. “Theo’s depth and breadth of experience in clinical development across a range of therapeutic areas wiFirst Patient Dosed in Complexa Phase 2 Trial of Lead Candidate CXA-10 to Treat Pulmonary Arterial Hypertension
BERWYN, Pa.--(BUSINESS WIRE)--Complexa Inc. today announced dosing of the first patient in PRIMEx, a Phase 2 clinical trial evaluating the safety and efficacy of two doses of the company’s lead candidate, CXA-10, to treat pulmonary arterial hypertension (PAH). PAH is a rare, progressive disease characterized by high blood pressure in the vessels that carry blood from the right side of the heart to the lungs, which can compromise the normal function of the heart. It
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Complexa
Sign Up For FreeTo access detailed company insights
Complexa Inc. is a clinical stage biopharmaceutical company focused on transforming the lives of patients burdened with severe and life-threatening fibrosis and inflammatory diseases.... Read More
